Algo version: 0.98b
Welgene Biotech CoLtd is listed at the TWO Exchange
Welgene Biotech CoLtd [6661.TWO]
TWO Sector: Healthcare Industry:Medical Diagnostics Research

Is Welgene Biotech CoLtd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Welgene Biotech CoLtd pays dividends. Last time was Tuesday 11th of April 2023 where the investors holding the stock on Thursday 16th of March 2023 were paid TWD0.18144 per share. Over the last 6 times between 2018 and 2023, Welgene Biotech CoLtd has paid TWD4.70732 with an average of TWD0.78 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Welgene Biotech CoLtd 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD25.68, you would have made a loss of TWD-1.130 per share or -4.40%

Yes, the average daily trading liquidity for Welgene Biotech CoLtd is TWD58 450 thousand. You should therefore be able to get in and out of your positions relatively fast.

Welgene Biotech CoLtd has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.32, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Welgene Biotech CoLtd to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.